Locus Biosciences Funding: $74M Raised, Series B (2022)
Locus Biosciences is based in Parsippany, New Jersey. It has raised $74M in total funding. Latest round: Series B.
Locus Biosciences funding overview
Locus Biosciences is based in Parsippany, New Jersey. Locus Biosciences has raised $74M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for Locus Biosciences runs through 2022; nothing later has been disclosed. Investors on record include Artis Ventures, Viking Global Investors, Johnson & Johnson Development Corporation (JJDC), Hercules Capital. 4 distinct backers are named across the disclosed rounds.
Locus Biosciences at a glance
Total raised
$74M
Latest round
Series B
Latest round date
January 2022
Headquarters
Parsippany, New Jersey
Notable investors
Artis Ventures, Viking Global Investors, Johnson & Johnson Development Corporation (JJDC), Hercules Capital
Frequently asked about Locus Biosciences funding
How much has Locus Biosciences raised?
Locus Biosciences has raised $74M in total disclosed funding across the rounds on record.
Who has invested in Locus Biosciences?
Artis Ventures, Viking Global Investors, Johnson & Johnson Development Corporation (JJDC), Hercules Capital are named among the investors backing Locus Biosciences.
What was the latest Locus Biosciences funding round?
The most recent disclosed round is a Series B, announced in January 2022.
Where is Locus Biosciences based?
Locus Biosciences is based in Parsippany, New Jersey.
When did Locus Biosciences last raise?
The last disclosed Locus Biosciences round closed in January 2022 at Series B.
Round data for Locus Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Parsippany and backer lists below.
